In the pivotal STRATUM trial, nearly 80% of individuals achieved the primary efficacy endpoint of Investigators Global Assessment (IGA) Success, with just over 50% reaching complete clearance at week 8
One of the most important is GLP-1 (glucagon-like peptide-1), which slows digestion, reduces appetite, and helps the pancreas release insulin
Moreover, oral peptides come with a catch: they require much higher quantities of active ingredient than injectables to achieve similar efficacy
If alcohol or addiction is part of your story and you need support, please refer to the resources below: Australia National Alcohol and Other Drug Hotline: 1800 250 015 UK Drinkline national alcohol helpline on 0300 123 1110 US SAMHSA National Helpline 1-800-662-HELP About This Podcast The GLP-1 Diaries is a podcast built from real human conversations in patient forums, exploring the stories, patterns, and questions shaping the GLP-1 era.
Begin your personalized treatment plan Depending on your symptoms or conditions, we will begin our therapies at a recommended rhythm while monitoring your experience and results at every step